We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The University of Sheffield and Parkinson’s UK have launched a new £1-million virtual biotech company as part of a research programme to create novel medicines for Parkinson’s disease.